Adicet Bio to join H.C. Wainwright fireside chat
Adicet Bio, Inc. (Nasdaq: ACET) announced CEO Chen Schor will participate in a fireside chat at H.C. Wainwright’s 28th Annual Global Investment Conference.
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced that Chen Schor, President and Chief Executive Officer…